The report covers Probi's business model and its links to sustainability. It includes a materiality assessment that identifies key sustainability issues and Probi's stakeholders. The report outlines Probi's vision to improve the health and well-being of people around the world, and highlights the company's commitment to ethical business practices, resource efficiency, and a healthy and equal workplace. It also details Probi's contributions to the UN's Sustainable Development Goals, particularly in the areas of good health and well-being, responsible consumption and production, and climate action. Specific highlights of the report include Probi's partnership with Sinopharm to expand the portfolio of ClinBac™™ and LiveBac® probiotics in China, its efforts to achieve climate neutrality by 2040, and its new hybrid working model for employees. The report emphasizes the company's focus on continuous improvement and its commitment to transparency and accountability.
